{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:47:39Z","timestamp":1778600859756,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Henan Provincial","award":["NO. 242300421499"],"award-info":[{"award-number":["NO. 242300421499"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86397-x","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T12:04:07Z","timestamp":1747137847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of potential metabolic biomarkers and immune cell infiltration for metabolic associated steatohepatitis by bioinformatics analysis and machine learning"],"prefix":"10.1038","volume":"15","author":[{"given":"Haoran","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"5","key":"86397_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77 (5), 1797\u20131835 (2023).","journal-title":"Hepatology"},{"issue":"1","key":"86397_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1210\/endrev\/bnz009","volume":"41","author":"T Marjot","year":"2020","unstructured":"Marjot, T. et al. Nonalcoholic fatty liver disease in adults: Current concepts in etiology, outcomes, and management. Endocr. Rev. 41 (1), 66\u2013117 (2020).","journal-title":"Endocr. Rev."},{"issue":"1","key":"86397_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12072-021-10286-4","volume":"16","author":"HM Zou","year":"2022","unstructured":"Zou, H. M. et al. Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: A systematic review. Hep. Intl. 16 (1), 27\u201337 (2022).","journal-title":"Hep. Intl."},{"issue":"2","key":"86397_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq, N. et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 7 (2), 234\u2013238 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"86397_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78 (6), 1966\u20131986 (2023).","journal-title":"Hepatology"},{"issue":"5","key":"86397_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/biomedicines10051015","volume":"10","author":"P Gabriel-Medina","year":"2022","unstructured":"Gabriel-Medina, P. et al. Influence of type 2 diabetes in the association of PNPLA3 rs738409 and TM6SF2 rs58542926 polymorphisms in NASH advanced liver fibrosis. Biomedicines 10 (5), 1015 (2022).","journal-title":"Biomedicines"},{"issue":"11","key":"86397_CR7","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.cgh.2022.11.002","volume":"21","author":"E Vilar-Gomez","year":"2023","unstructured":"Vilar-Gomez, E. et al. The protection conferred by HSD17B13 rs72613567 on hepatic fibrosis is likely mediated by lowering ballooning and portal inflammation. Clin. Gastroenterol. Hepatol. 21 (11), 2981\u20132983e3 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86397_CR8","doi-asserted-by":"publisher","first-page":"102589","DOI":"10.1016\/j.artmed.2023.102589","volume":"143","author":"T Yuan","year":"2023","unstructured":"Yuan, T. et al. Machine learning in the identification of prognostic DNA methylation biomarkers among patients with cancer: A systematic review of epigenome-wide studies. Artif. Intell. Med. 143, 102589 (2023).","journal-title":"Artif. Intell. Med."},{"issue":"7","key":"86397_CR9","doi-asserted-by":"publisher","first-page":"103353","DOI":"10.1016\/j.autrev.2023.103353","volume":"22","author":"MG Danieli","year":"2023","unstructured":"Danieli, M. G. et al. A machine learning analysis to evaluate the outcome measures in inflammatory myopathies. Autoimmun. Rev. 22 (7), 103353 (2023).","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"86397_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12967-022-03734-8","volume":"20","author":"Z He","year":"2022","unstructured":"He, Z. et al. Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease. J. Transl. Med. 20 (1), 529 (2022).","journal-title":"J. Transl. Med."},{"issue":"1","key":"86397_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12944-023-01988-9","volume":"23","author":"L Dai","year":"2024","unstructured":"Dai, L. et al. Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis. Lipids Health Dis. 23 (1), 23 (2024).","journal-title":"Lipids Health Dis."},{"issue":"14","key":"86397_CR12","doi-asserted-by":"publisher","first-page":"e32783","DOI":"10.1016\/j.heliyon.2024.e32783","volume":"10","author":"R Yu","year":"2024","unstructured":"Yu, R. et al. Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis. Heliyon 10 (14), e32783 (2024).","journal-title":"Heliyon"},{"issue":"43","key":"86397_CR13","doi-asserted-by":"publisher","first-page":"15538","DOI":"10.1073\/pnas.1412759111","volume":"111","author":"S Horvath","year":"2014","unstructured":"Horvath, S. et al. Obesity accelerates epigenetic aging of human liver. Proc. Natl. Acad. Sci. U S A. 111 (43), 15538\u201315543 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"86397_CR14","doi-asserted-by":"publisher","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","volume":"316","author":"MP Suppli","year":"2019","unstructured":"Suppli, M. P. et al. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am. J. Physiol. Gastrointest. Liver Physiol. 316 (4), G462\u2013g472 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"86397_CR15","doi-asserted-by":"publisher","first-page":"e0124544","DOI":"10.1371\/journal.pone.0124544","volume":"10","author":"I Frades","year":"2015","unstructured":"Frades, I. et al. Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic fatty liver disease. PLoS One. 10 (5), e0124544 (2015).","journal-title":"PLoS One"},{"issue":"5","key":"86397_CR16","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/hep.27695","volume":"61","author":"BM Arendt","year":"2015","unstructured":"Arendt, B. M. et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology 61 (5), 1565\u20131578 (2015).","journal-title":"Hepatology"},{"issue":"2","key":"86397_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","volume":"18","author":"M Ahrens","year":"2013","unstructured":"Ahrens, M. et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell. Metab. 18 (2), 296\u2013302 (2013).","journal-title":"Cell. Metab."},{"issue":"2","key":"86397_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gutjnl-2012-303179","volume":"63","author":"C L\u00f3pez-Vicario","year":"2014","unstructured":"L\u00f3pez-Vicario, C. et al. Molecular interplay between \u22065\/\u22066 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut 63 (2), 344\u2013355 (2014).","journal-title":"Gut"},{"issue":"3","key":"86397_CR19","doi-asserted-by":"publisher","first-page":"e9570","DOI":"10.1371\/journal.pone.0009570","volume":"5","author":"SS Baker","year":"2010","unstructured":"Baker, S. S. et al. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS One. 5 (3), e9570 (2010).","journal-title":"PLoS One"},{"key":"86397_CR20","doi-asserted-by":"crossref","unstructured":"Govaere, O. et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci. Transl. Med., 12(572). (2020).","DOI":"10.1126\/scitranslmed.aba4448"},{"key":"86397_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy, T. et al. Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum. Annu. Rev. Pathol. 11, 451\u2013496 (2016).","journal-title":"Annu. Rev. Pathol."},{"key":"86397_CR22","doi-asserted-by":"crossref","unstructured":"Ferdous, S. E. & Ferrell, J. M. Pathophysiological relationship between type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: Novel therapeutic approaches. Int. J. Mol. Sci., 25(16). (2024).","DOI":"10.3390\/ijms25168731"},{"issue":"9","key":"86397_CR23","first-page":"815","volume":"12","author":"X Feng","year":"2024","unstructured":"Feng, X. et al. Mechanism of metabolic dysfunction-associated steatotic liver disease: Important role of lipid metabolism. J. Clin. Transl. Hepatol. 12 (9), 815\u2013826 (2024).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"86397_CR24","doi-asserted-by":"publisher","first-page":"111846","DOI":"10.1016\/j.diabres.2024.111846","volume":"217","author":"S Gancheva","year":"2024","unstructured":"Gancheva, S., Roden, M. & Castera, L. Diabetes as a risk factor for MASH progression. Diabetes Res. Clin. Pract. 217, 111846 (2024).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"86397_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/stem.2454","volume":"35","author":"W Wruck","year":"2017","unstructured":"Wruck, W. et al. Concise review: Current status and future directions on research related to nonalcoholic fatty liver disease. Stem Cells. 35 (1), 89\u201396 (2017).","journal-title":"Stem Cells"},{"key":"86397_CR26","doi-asserted-by":"crossref","unstructured":"du Plessis, J. et al. Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology, 149(3), 635\u2009\u2013\u200948.e14 (2015).","DOI":"10.1053\/j.gastro.2015.05.044"},{"key":"86397_CR27","doi-asserted-by":"publisher","first-page":"150068","DOI":"10.1038\/sdata.2015.68","volume":"2","author":"W Wruck","year":"2015","unstructured":"Wruck, W. et al. Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes. Sci. Data. 2, 150068 (2015).","journal-title":"Sci. Data"},{"issue":"6","key":"86397_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/metabo11060332","volume":"11","author":"S Endo","year":"2021","unstructured":"Endo, S., Matsunaga, T. & Nishinaka, T. The role of AKR1B10 in physiology and pathophysiology. Metabolites 11 (6), 332 (2021).","journal-title":"Metabolites"},{"key":"86397_CR29","doi-asserted-by":"crossref","unstructured":"Lin, X. L. et al. Nicotinate-curcumin improves NASH by inhibiting the AKR1B10\/ACC\u03b1-mediated triglyceride synthesis. Lipids Health Dis. 23(1). (2024).","DOI":"10.1186\/s12944-024-02162-5"},{"key":"86397_CR30","doi-asserted-by":"crossref","unstructured":"Choi, S. J. et al. A composite blood biomarker including AKR1B10 and cytokeratin 18 for progressive types of nonalcoholic fatty liver disease. Diabetes Metab. J. 48(4). (2024).","DOI":"10.4093\/dmj.2023.0189"},{"key":"86397_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-nutr-082018-124250","volume":"39","author":"B Koletzko","year":"2019","unstructured":"Koletzko, B. et al. FADS1 and FADS2 polymorphisms modulate fatty acid metabolism and dietary Impact on Health. Annu. Rev. Nutr. 39, 21\u201344 (2019).","journal-title":"Annu. Rev. Nutr."},{"key":"86397_CR32","doi-asserted-by":"crossref","unstructured":"Lim, M. Y. C. & Ho, H. K. Pharmacological modulation of cholesterol 7\u03b1-hydroxylase as a therapeutic strategy for hypercholesterolemia. Biochem. Pharmacol. 220 (2024).","DOI":"10.1016\/j.bcp.2023.115985"},{"issue":"3","key":"86397_CR33","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/hep.24107","volume":"53","author":"TG Li","year":"2011","unstructured":"Li, T. G. et al. Overexpression of cholesterol 7\u03b1-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 53 (3), 996\u20131006 (2011).","journal-title":"Hepatology"},{"issue":"8","key":"86397_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4254\/wjh.v9.i8.443","volume":"9","author":"W Wruck","year":"2017","unstructured":"Wruck, W. & Adjaye, J. Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease. World J. Hepatol. 9 (8), 443\u2013454 (2017).","journal-title":"World J. Hepatol."},{"issue":"5","key":"86397_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/1297-9686-40-5-563","volume":"40","author":"J Wu","year":"2008","unstructured":"Wu, J. et al. Characterization of porcine ENO3: Genomic and cDNA structure, polymorphism and expression. Genet. Sel. Evol. 40 (5), 563\u2013579 (2008).","journal-title":"Genet. Sel. Evol."},{"key":"86397_CR36","doi-asserted-by":"crossref","unstructured":"Lu, D. et al. ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation. Ann. Transl. Med. 9(8). (2021).","DOI":"10.21037\/atm-21-471"},{"key":"86397_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20080595","volume":"414","author":"L Agius","year":"2008","unstructured":"Agius, L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem. J. 414, 1\u201318 (2008).","journal-title":"Biochem. J."},{"issue":"4","key":"86397_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/hep.24793","volume":"55","author":"LP Bechmann","year":"2012","unstructured":"Bechmann, L. P. et al. Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology 55 (4), 1083\u20131093 (2012).","journal-title":"Hepatology"},{"key":"86397_CR39","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. MicroRNA-34a mediates high-fat-induced hepatic insulin resistance by targeting ENO3. Nutrients 15(21). (2023).","DOI":"10.3390\/nu15214616"},{"issue":"9","key":"86397_CR40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/hep4.1396","volume":"3","author":"N Dali-Youcef","year":"2019","unstructured":"Dali-Youcef, N. et al. Interleukin-32 contributes to human nonalcoholic fatty liver disease and insulin resistance. Hepatol. Commun. 3 (9), 1205\u20131220 (2019).","journal-title":"Hepatol. Commun."},{"issue":"5","key":"86397_CR41","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s12276-024-01222-1","volume":"56","author":"S Oh","year":"2024","unstructured":"Oh, S. et al. Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases. Exp. Mol. Med. 56 (5), 1066\u20131079 (2024).","journal-title":"Exp. Mol. Med."},{"issue":"1\u20132","key":"86397_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/A:1027332523114","volume":"254","author":"J Swierczynski","year":"2003","unstructured":"Swierczynski, J. et al. Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Mol. Cell. Biochem. 254 (1\u20132), 55\u201359 (2003).","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"86397_CR43","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese, M. et al. Innate immunity and inflammation in NAFLD\/NASH. Dig. Dis. Sci. 61 (5), 1294\u20131303 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"86397_CR44","doi-asserted-by":"publisher","first-page":"1302006","DOI":"10.3389\/fimmu.2023.1302006","volume":"14","author":"VR Adams","year":"2023","unstructured":"Adams, V. R. et al. Myeloid cell MHC I expression drives CD8(+) T cell activation in nonalcoholic steatohepatitis. Front. Immunol. 14, 1302006 (2023).","journal-title":"Front. Immunol."},{"issue":"2","key":"86397_CR45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/hep.30952","volume":"71","author":"A Torres-Hernandez","year":"2020","unstructured":"Torres-Hernandez, A. et al. \u03b3\u03b4 T cells promote steatohepatitis by orchestrating innate and adaptive Iimmune programming. Hepatology 71 (2), 477\u2013494 (2020).","journal-title":"Hepatology"},{"key":"86397_CR46","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1038\/ncomms13839","volume":"7","author":"F Li","year":"2017","unstructured":"Li, F. et al. The microbiota maintain homeostasis of liver-resident \u03b3\u03b4T-17 cells in a lipid antigen\/CD1d-dependent manner. Nat. Commun. 7, 13839 (2017).","journal-title":"Nat. Commun."},{"issue":"1","key":"86397_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcmgh.2021.08.019","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Activated natural killer cell promotes nonalcoholic Steatohepatitis through mediating JAK\/STAT pathway. Cell. Mol. Gastroenterol. Hepatol. 13 (1), 257\u2013274 (2022).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"86397_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann, F. & Tacke, F. Immunology in the liver\u2013from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol. 13 (2), 88\u2013110 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"41","key":"86397_CR49","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.3748\/wjg.v22.i41.9096","volume":"22","author":"CM Chackelevicius","year":"2016","unstructured":"Chackelevicius, C. M. et al. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. World J. Gastroenterol. 22 (41), 9096\u20139103 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"86397_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau, M. et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver. J. Immunol. 196 (1), 97\u2013105 (2016).","journal-title":"J. Immunol."},{"issue":"7739","key":"86397_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-018-0812-9","volume":"565","author":"SL Park","year":"2019","unstructured":"Park, S. L. et al. Tissue-resident memory CD8(+) T cells promote melanoma-immune equilibrium in skin. Nature 565 (7739), 366\u2013371 (2019).","journal-title":"Nature"},{"issue":"3","key":"86397_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41590-018-0298-5","volume":"20","author":"S Zundler","year":"2019","unstructured":"Zundler, S. et al. Hobit- and Blimp-1-driven CD4(+) tissue-resident memory T cells control chronic intestinal inflammation. Nat. Immunol. 20 (3), 288\u2013300 (2019).","journal-title":"Nat. Immunol."},{"issue":"1","key":"86397_CR53","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","volume":"12","author":"Y Koda","year":"2021","unstructured":"Koda, Y. et al. CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat. Commun. 12 (1), 4474 (2021).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86397-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:03:04Z","timestamp":1747526584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86397-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86397"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86397-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16596"}}